The University of Chicago Header Logo

Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma.

Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma. Blood Cancer J. 2022 07 11; 12(7):108.

View in: PubMed